Continuum Advisory LLC increased its holdings in Accenture plc (NYSE:ACN – Free Report) by 86.6% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,299 shares of the information technology services provider’s stock after acquiring an additional 603 shares during the quarter. Continuum Advisory LLC’s holdings in Accenture were worth $470,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in ACN. Morse Asset Management Inc purchased a new stake in shares of Accenture during the 3rd quarter worth $25,000. Unique Wealth Strategies LLC purchased a new stake in shares of Accenture during the second quarter valued at about $26,000. Strategic Financial Concepts LLC bought a new stake in shares of Accenture in the 2nd quarter valued at about $28,000. MidAtlantic Capital Management Inc. purchased a new position in shares of Accenture in the 3rd quarter worth approximately $30,000. Finally, Mowery & Schoenfeld Wealth Management LLC lifted its position in Accenture by 607.1% during the third quarter. Mowery & Schoenfeld Wealth Management LLC now owns 99 shares of the information technology services provider’s stock valued at $35,000 after acquiring an additional 85 shares during the last quarter. 75.14% of the stock is currently owned by institutional investors.
Accenture Price Performance
ACN opened at $362.98 on Wednesday. The stock has a market cap of $226.92 billion, a P/E ratio of 31.75, a P/E/G ratio of 3.22 and a beta of 1.24. The firm has a fifty day moving average price of $360.26 and a 200 day moving average price of $333.42. Accenture plc has a 1 year low of $278.69 and a 1 year high of $387.51.
Accenture announced that its Board of Directors has initiated a stock repurchase plan on Thursday, September 26th that allows the company to buyback $4.00 billion in shares. This buyback authorization allows the information technology services provider to buy up to 1.8% of its shares through open market purchases. Shares buyback plans are generally an indication that the company’s management believes its shares are undervalued.
Accenture Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Thursday, October 10th were given a dividend of $1.48 per share. This is a positive change from Accenture’s previous quarterly dividend of $1.29. The ex-dividend date was Thursday, October 10th. This represents a $5.92 dividend on an annualized basis and a dividend yield of 1.63%. Accenture’s dividend payout ratio (DPR) is 51.79%.
Insider Buying and Selling
In other Accenture news, CEO Ryoji Sekido sold 3,191 shares of the firm’s stock in a transaction on Monday, November 4th. The stock was sold at an average price of $343.70, for a total value of $1,096,746.70. Following the transaction, the chief executive officer now owns 6 shares in the company, valued at approximately $2,062.20. This trade represents a 99.81 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Angela Beatty sold 673 shares of the company’s stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $372.18, for a total transaction of $250,477.14. Following the sale, the insider now directly owns 5,650 shares of the company’s stock, valued at $2,102,817. The trade was a 10.64 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 36,298 shares of company stock valued at $13,372,661. 0.07% of the stock is owned by corporate insiders.
Wall Street Analysts Forecast Growth
ACN has been the topic of several analyst reports. Barclays lifted their price target on shares of Accenture from $350.00 to $415.00 and gave the stock an “overweight” rating in a report on Monday, September 30th. Guggenheim increased their price target on Accenture from $380.00 to $395.00 and gave the company a “buy” rating in a research note on Friday, September 27th. The Goldman Sachs Group upgraded Accenture from a “neutral” rating to a “buy” rating and boosted their price target for the stock from $370.00 to $420.00 in a research note on Friday, December 6th. TD Cowen raised shares of Accenture from a “hold” rating to a “buy” rating and increased their price objective for the company from $321.00 to $400.00 in a research report on Monday, September 30th. Finally, Robert W. Baird reissued a “neutral” rating and set a $370.00 target price on shares of Accenture in a research report on Tuesday, December 3rd. Eight analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $372.09.
Check Out Our Latest Analysis on ACN
Accenture Profile
Accenture plc, a professional services company, provides strategy and consulting, industry X, song, and technology and operation services worldwide. The company offers application services, including agile transformation, DevOps, application modernization, enterprise architecture, software and quality engineering, data management; intelligent automation comprising robotic process automation, natural language processing, and virtual agents; and application management services, as well as software engineering services; strategy and consulting services; data and analytics strategy, data discovery and augmentation, data management and beyond, data democratization, and industrialized solutions comprising turnkey analytics and artificial intelligence (AI) solutions; metaverse; and sustainability services.
See Also
- Five stocks we like better than Accenture
- What Are the U.K. Market Holidays? How to Invest and Trade
- Survey Reveals: Which States Saw the Biggest Investment Gains in 2024?
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Amazon’s Healthcare Gamble: A New Era of Medical Disruption
- Expert Stock Trading Psychology Tips
- Semiconductor Giant Synopsys Slides 14% — Time to Take Notice
Receive News & Ratings for Accenture Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accenture and related companies with MarketBeat.com's FREE daily email newsletter.